Pharmaceuticals This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 7.

Quest Diagnostics to Sell HemoCue Business to Radiometer Medical ApS
MADISON, N.J., Feb. 25, 2013 -- (Healthcare Sales & Marketing Network) -- Quest Diagnostics (DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to sell its HemoCue diagnostic pr... Diagnostics, AcquisitionsQuest Diagnostics, Radiometer Medical, HemoCue
Source: HSMN NewsFeed - February 25, 2013 Category: Pharmaceuticals Source Type: news

2 Drug Companies Announce Anemia Drug Recall
From Associated Press (February 24, 2013) WASHINGTON -- Drug companies Affymax Inc. and Takeda Pharmaceutical Co. have issued a recall of their anemia drug Omontys after reports of severe allergic reactions in some kidney dialysis patients,...
Source: Drugs.com - Pharma News - February 25, 2013 Category: Pharmaceuticals Source Type: news

SteriBeam Systems-Pulsed UV and PEF Non-Invasive Sterilisation Systems
SteriBeam Systems is a developer of quick, non-invasive sterilisation systems that use intense pulsed UV or PEF fields for R&D and production. These systems enable the sterilisation of pharmaceutical...
Source: Pharmaceutical Technology - February 25, 2013 Category: Pharmaceuticals Source Type: news

Omontys (peginesatide) Injection by Affymax and Takeda: Recall of All Lots - Serious Hypersensitivity Reactions
AUDIENCE: Patients, Healthcare Professionals, Hematology ISSUE: Affymax, Inc. and Takeda Pharmaceutical Company Limited along with the U.S. Food and Drug Administration (FDA) are informing the public of a voluntary recall of all lots of OMONTYS®...
Source: Drugs.com - Pharma News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Will Medicaid Expansion Create Jobs?
Florida Governor Rick Scott’s stunning reversal on Medicaid expansion came on the same day a report was released that said expansion would create 71,300 jobs by 2016. Ron Pollak, the head of FamiliesUSA (which sponsored the study) even said that if the state says no to the federal funding, it "would be an act of fiscal malpractice." Admittedly, the governor has not yet said whether this potential impact on jobs influenced his turnabout, impact. But given the anemic pace of the current economic recovery, there’s little doubt that this side-effect of Medicaid expansion might be an important factor for states that f...
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Chris Conover Source Type: news

Ten Health Benefits Of Fiber
Ten health benefits of increasing fiber in your diet
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

This Tasty Diet Can Prevent Heart Attacks And Strokes, Study Says
A large study conducted with funding from the Spanish government appears to have settled an old debate: What should people eat to avoid having a heart attack or stroke? It turns out it may not be how much fat you eat but what kind.
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

Large Trial Shows Cardiovascular Benefits Of Mediterranean Diet
A large new trial offers powerful evidence that a Mediterranean diet can reduce the risk for cardiovascular disease. Results of the PREDIMED (Prevención con Dieta Mediterránea) study were published online in the New England Journal of Medicine.
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

¡Olé! How the New Spanish Study Should Change Your Diet
Today the New England Journal of Medicine has published a Spanish study comparing two versions of the Mediterranean diet with a low fat diet and the result is important news if you are interested in reducing your risk of heart disease and stroke. They compared a Mediterranean diet that emphasized extra virgin olive oil, a Mediterranean diet that emphasized nuts and a low fat diet. The Mediterranean diets were the big winners; they reduced the risk of the combination of heart attack, stroke or death from cardiovascular causes by about 30%!
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Harlan Krumholz Source Type: news

Royalty Pharma proposes $6.6 billion bid for Elan
DUBLIN (Reuters) - Investment firm Royalty Pharma has made a $6.6 billion bid approach to Elan, seeking to scupper the Irish drugmaker's plan to spend most of the proceeds from a major drug sale on deals and instead give the money to shareholders.
Source: Reuters: Health - February 25, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Teva CEO: No New Acquisitions Planned
From Globes (Tel Aviv) (February 24, 2013) Feb. 24--In an interview with "Yediot Ahronot", Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) president and CEO Jeremy Levin was asked if the company had plans to renew its...
Source: Drugs.com - Pharma News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Merck to Pay Pennsylvania $8.5 Million in Vioxx Case
From Philadelphia Inquirer (PA) (February 24, 2013) Feb. 24--Merck & Co. Inc., will pay $8.5 million to settle allegations by the Commonwealth of Pennsylvania that the drugmaker inappropriately marketed its controversial painkiller Vioxx,...
Source: Drugs.com - Pharma News - February 25, 2013 Category: Pharmaceuticals Source Type: news

FDA Alerts Healthcare Providers of Recall of Anemia Drug Omontys
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfield,...
Source: Drugs.com - Pharma News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Royalty Pharma in $6.6bn bid for Elan
Investment group seeks to take control of Dublin-based group for access to future income from Elan’s multiple sclerosis drug Tysabri
Source: FT.com - Drugs and Healthcare - February 25, 2013 Category: Pharmaceuticals Source Type: news

Third Annual Medical Pharmacy Trend Report Illuminates Hidden Healthcare Costs
Industry reporting on specialty pharmaceuticals has historically left out medications covered and paid for under the medical benefit. This is the only detailed drug trend report available for those medicines administered by providers and billed under the medical benefit. Specialty drug costs increased 16 percent for the top 25 therapies.
Source: Pharmaceutical Online News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Energy Efficient Tips For Compressed Air Preparation & Energy Monitoring
There are several factors to take into consideration in order to find the most energy efficient compressed air preparation design.
Source: Pharmaceutical Online News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Selecting The Most Energy Efficient Mechanical & Vacuum Grippers
When designing a automation system one must become aware of the specific properties of the application to make an ideal selection. Festo’s software can help evaluate the most energy efficient grippers and vacuums.
Source: Pharmaceutical Online News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Tips For Selecting The Most Energy Efficient Valves & Valve Terminals
To find the most efficient valves and valve terminals Festo provides a software tools that help configure the most suitable product for your needs.
Source: Pharmaceutical Online News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Tips For Selecting Energy Efficient Pneumatic And Electric Drives
When designing a system, the measures and drive technology combinations that are most energy-efficient must be considered at the planning stage, and one must become aware of the specific properties of the application to make an ideal selection.
Source: Pharmaceutical Online News - February 25, 2013 Category: Pharmaceuticals Source Type: news

Almac Passes FDA Inspection
The business unit of Almac Sciences has successfully completed an inspection of its analytical facilities at the Craigavon Headquarters in Northern Ireland. The inspection was conducted by the US Food and Drug Administration (FDA). After observing roughly 483 points, there were no objectionable conditions found and no improvement recommendations.
Source: PharmaManufacturing.com - February 25, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

ALUMINUM ACETATE ASTRINGENTpowder, For Solution [Epic Pharma, LLC]
Updated Date: Feb 25, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 25, 2013 Category: Drugs & Pharmacology Source Type: news

IRBESARTAN AND HYDROCHLOROTHIAZIDEtablet, Film Coated [Aurobindo Pharma Limited]
Updated Date: Feb 25, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 25, 2013 Category: Drugs & Pharmacology Source Type: news

SPECTRACEF (Cefditoren Pivoxil) Tablet, Film Coated SPECTRACEF (Cefditoren Pivoxil) Tablet, Film Coated [Vansen Pharma Inc.]
Updated Date: Feb 25, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 25, 2013 Category: Drugs & Pharmacology Source Type: news

Ranbaxy restarts production of generic Lipitor for US market
"We are working with the USFDA, and have identified and implemented multiple corrective and preventive actions," Ranbaxy said.
Source: The Economic Times Healthcare and Biotech News - February 24, 2013 Category: Pharmaceuticals Source Type: news

Takeda pulls anemia drug Omontys after fatal hypersensitivity reactions
Anemia drug Omontys has been voluntarily recalled in the US after reports of some patients experiencing hypersensitivity reactions, including death, according to Takeda Pharmaceutical and Affymax, who produce the drug.
Source: Pharmaceutical Technology - February 24, 2013 Category: Pharmaceuticals Source Type: news

Brain cells’ ability to survive stroke explained by UK scientists
Scientists in the UK hope to develop a drug that imitates the brain's ability to protect itself from damage caused by a stroke after explaining why certain neurons can withstand being starved from oxygen for the first time in history.
Source: Pharmaceutical Technology - February 24, 2013 Category: Pharmaceuticals Source Type: news

Cangene to explore Alzheimer's disease therapies using UBC technology
Canada-based biopharmaceutical company Cangene is planning to use new technology developed at The University of British Columbia (UBC) to advance Alzheimer's disease research.
Source: Drug Development Technology - February 24, 2013 Category: Pharmaceuticals Source Type: news

FDA approves Genentech metastatic breast cancer drug
The US Food and Drug Administration (FDA) has approved Genentech's Kadcyla (ado-trastuzumab emtansine or T-DM1) for the treatment of HER2-positive metastatic breast cancer (mBC).
Source: Drug Development Technology - February 24, 2013 Category: Pharmaceuticals Source Type: news

Eriez E-Z Tec DSP Metal Detectors Safeguard Against Ferrous, Nonferrous And Stainless Steel Contaminants
The Eriez line of extremely sensitive E-Z Tec DSP Metal Detectors offers a powerful solution for detecting ferrous, nonferrous and stainless steel contaminants.
Source: Pharmaceutical Online News - February 24, 2013 Category: Pharmaceuticals Source Type: news

Google Glass V2 Could Be Binocular, And Even Double As Stealth Hearing Aids
Now that the first version of Google Glass is out in the wild, it is time to turn our gaze to what's next. Certainly that's what Google co-founder Sergey Brin, the lead inventor on the project, is doing.
Source: Forbes.com Healthcare News - February 24, 2013 Category: Pharmaceuticals Authors: Anthony Wing Kosner Source Type: news

Generic-Drugs Court Decision Irks Businesses
Business groups are urging Alabama's highest court to reconsider its recent ruling that name-brand drug makers can be held liable for injuries caused by the generic versions of their products.
Source: WSJ.com: Health - February 24, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

Novartis’ U-turn marks a crossroads
Debate around retirement package for Vasella was latest flashpoint over pay between some shareholders in Switzerland and group’s aspirations
Source: FT.com - Drugs and Healthcare - February 24, 2013 Category: Pharmaceuticals Source Type: news

Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against Longwei Petroleum Investment Holding Limited -- LPH
LOS ANGELES, Feb. 23, 2013 (GLOBE NEWSWIRE) -- Glancy Binkow & Goldberg LLP, representing investors of Longwei Petroleum Investment Holding Limited ("Longwei" or the "Company") (NYSE MKT:LPH), has filed a shareholder lawsuit in the United States District Court for the Southern District of New York on behalf of a class (the "Class") comprising all persons or entities who purchased Longwei common stock between May 17, 2010 and January 3, 2013, inclusive (the "Class Period"). Investors who have losses of $100,000 or more are encouraged to contact the firm for information concerning a lead plaintiff position in the class actio...
Source: Medical News (via PRIMEZONE) - February 24, 2013 Category: Pharmaceuticals Source Type: news

Rosen Law Firm Files Securities Fraud Class Action Against Poseidon Concepts Corp.-- POOSF
NEW YORK, Feb. 23, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. today announced that it has filed a class action lawsuit on behalf of investors who purchased the stock of Poseidon Concepts Corp. (OTC:POOSF) during the period from May 9, 2012 to February 14, 2013 seeking to recover damages for violations of the federal securities laws.
Source: Medical News (via PRIMEZONE) - February 24, 2013 Category: Pharmaceuticals Source Type: news

The agreement on transfer of Ūkio bankas AB assets, rights, transactions and liabilities was signed
On February 23, 2013 Šiaulių bankas AB, the temporary administrator of Ūkio bankas and the State undertaking „Deposit and Investment Insurance“ signed the agreement on transfer of the share of Ūkio bankas AB assets, rights, transactions and liabilities. According to the present agreement Šiaulių bankas shall take over the liabilities to the clients in the amount of LTL 2.7 billion. The total value of the transferable assets and the amount payable by the State undertaking „Deposit an
Source: Medical News (via PRIMEZONE) - February 24, 2013 Category: Pharmaceuticals Source Type: news

The subordinated loan agreement was signed
On February 23, 2013 Šiaulių bankas signed the agreement with the European Bank for Reconstruction and Development according to which the EBRD grants the subordinated loan to Šiaulių bankas in the amount of EUR 20 million for the period of 10 years. The purpose of the loan is to strengthen the capital base of Šiaulių bankas while taking over the share of Ūkio bankas assets and liabilities Chief Executive Officer Audrius Žiugžda
Source: Medical News (via PRIMEZONE) - February 24, 2013 Category: Pharmaceuticals Source Type: news

Leading Glendale AZ Pain Management Clinic, Arizona Pain Specialists,...
The leading pain clinic in Glendale AZ and the West Valley, Arizona Pain Specialists, is now providing platelet rich plasma therapy for patients. PRP is an effective regenerative medicine treatment...(PRWeb February 23, 2013)Read the full story at http://www.prweb.com/releases/painmanagementglendaleaz/painclinicwestvalley/prweb10463297.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

Leading Central Florida Pain Clinic, National Pain Institute, Now...
The premier pain clinic in Central Florida, National Pain Institute, is now offering platelet rich plasma treatment for patients. The treatment is an effective regenerative medicine technique for soft...(PRWeb February 23, 2013)Read the full story at http://www.prweb.com/releases/painmanagementocalafl/painclinicsflorida/prweb10462402.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Adds More...
Diet Doc increased the active ingredients in the prescription only saffron extract diet pills, improving their effectiveness for fast weight loss.(PRWeb February 23, 2013)Read the full story at http://www.prweb.com/releases/saffron-extract-diet-pill/fast-weight-loss/prweb10461691.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

Columbus Center for Women’s Health Research is participating in an...
Columbus Center for Women’s Health Research or CCWHR is participating in one of the largest clinical studies to ever explore a “use-as-needed” treatment, Tefina™, for women experiencing orgasmic...(PRWeb February 23, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10457472.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of...
The Firm is currently investigating Stryker hip lawsuits on behalf of individuals impacted by Stryker's recall of Rejuvenate and ABG II Modular-Neck Hip Stems.(PRWeb February 23, 2013)Read the full story at http://www.prweb.com/releases/stryker-hip-recall/stryker-rejuvenate-recall/prweb10461660.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

Wright Hip Implant Lawyers at Bernstein Liebhard LLP Note Scheduling...
Bernstein Liebhard LLP Now Investigating Wright Hip Implant Lawsuits Involving Wright Conserve Hip Replacements, Wright Profemur Hip Implants.(PRWeb February 24, 2013)Read the full story at http://www.prweb.com/releases/wright-conserve-hip/wright-profemur-hip/prweb10461767.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling...
The Firm continues to evaluate potential Actos lawsuits on behalf of patients who developed bladder cancer, allegedly due to long-term use of Actos.(PRWeb February 24, 2013)Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-bladder-cancer/prweb10461720.htm
Source: PRWeb: Medical Pharmaceuticals - February 24, 2013 Category: Pharmaceuticals Source Type: news

Are There Fewer Innovative Drugs In UK? No, There Are More
The idea that the supply of breakthrough drugs in the UK is drying up is a myth, researchers from Birmingham University reported in BMJ Open. In fact, the authors point out that if we look over the last four decades, the opposite seems to be the case - the supply of innovative pharmaceuticals in the UK has risen and continues to do so. For some reason, many in the press, medical profession, and even in the pharmaceutical industry believe that the medical innovation industry has been dwindling, with fewer innovative products coming onto the market today compared to decades ago...
Source: Health News from Medical News Today - February 24, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

PQM Tests Handheld Device For Detecting Counterfeit And Substandard Medicines
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines...
Source: Health News from Medical News Today - February 24, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

Today's Alternative Medicine Accidental Humor
Reiki Master Julie Motz, responding to The Operator, Michael Spector's excellent New Yorker piece on Dr. Oz: I never went near the heart-lung machine, but stood with my hands on the patient’s head for most of the surgery. In heart-transplant surgeries, I would go to the ice chest to
Source: Forbes.com Healthcare News - February 23, 2013 Category: Pharmaceuticals Authors: Peter Lipson Source Type: news

Martin Midstream Partners L.P. Investor Tax Reporting Packages Available On-Line, Tuesday, February 26, 2013
KILGORE, Texas, Feb. 22, 2013 (GLOBE NEWSWIRE) -- Martin Midstream Partners L.P. (Nasdaq:MMLP) announced today that its 2012 Investor Tax Reporting Packages will be available on the partnership's website at
Source: Medical News (via PRIMEZONE) - February 23, 2013 Category: Pharmaceuticals Source Type: news

Crown Castle International to Present at the Raymond James 34th Annual Institutional Investors Conference
HOUSTON, Feb. 22, 2013 (GLOBE NEWSWIRE) -- Crown Castle International Corp. (NYSE:CCI) announced today that Fiona McKone, Crown Castle's Vice President — Finance, is scheduled to present on Monday, March 4, 2013 at 4:35 p.m. Eastern Time at the Raymond James 34
Source: Medical News (via PRIMEZONE) - February 23, 2013 Category: Pharmaceuticals Source Type: news

Crown Castle International to Present at the Deutsche Bank 2013 dbAccess Media, Internet & Telecom Conference
HOUSTON, Feb. 22, 2013 (GLOBE NEWSWIRE) -- Crown Castle International Corp. (NYSE:CCI) announced today that Jay Brown, Crown Castle's Chief Financial Officer, is scheduled to present on Tuesday, March 5, 2013 at 2:05 p.m. Eastern Time at the Deutsche Bank 2013 dbAccess Media, Internet & Telecom Conference. Mr. Brown's presentation will be broadcast live over the Internet and is expected to last approximately 35 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle's website at
Source: Medical News (via PRIMEZONE) - February 23, 2013 Category: Pharmaceuticals Source Type: news

ARMOUR Residential REIT, Inc. Reports 16.2% Annualized ROE From Taxable REIT Income for Q4 2012
VERO BEACH, Fla., Feb. 22, 2013 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR, ARR PrA, and ARR PrB; NYSE MKT: ARR.WS) ("ARMOUR" or the "Company") today announced financial results for the quarter ended December 31, 2012.
Source: Medical News (via PRIMEZONE) - February 23, 2013 Category: Pharmaceuticals Source Type: news